Ruse Horse

In 2010, Sopharma AD had a profit of BGN 40.5 M, according to newly released company data.

Sopharma's 2010 revenues amounted to BGN 238.5 M, which is a 12% increase year-on-year.

30% of Sopharma's sales in 2010 were on Bulgaria's domestic market but the major factor for its revenue growth was its export to foreign markets which grew 19% compared with 2009.

Sopharma's 2010 gross expenditures amounted to BGN 193 M, an increase of 10% year-on-year.

Sopharma's own capital is BGN 296 M, which is a 16.6% increase in 2010 year-on-year.

In 2010, the pharmaceutical company's export to Russia increased by 20%, and to Ukraine – by 28%.

Tags: Sopharma, pharmaceutical companies, pharmaceuticals, pharmaceutical, export, exports, Russia, Ukraine